Matrix controlled transdermal system for stabile derivatives of ace inhibitors

Details for Australian Patent Application No. 2001281979 (hide)

Owner Hexal AG

Inventors Fischer, Wilfried; Klokkers, Karin; Kramer, Kai-Thomas; Sendl-Lang, Anna

Agent Watermark

Pub. Number AU-B-2001281979

PCT Pub. Number WO02/03970

Priority 10033855 12.07.00 DE

Filing date 12 July 2001

Wipo publication date 21 January 2002

Acceptance publication date 21 December 2006

International Classifications

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 38/55 (2006.01) Medicinal preparations containing peptides - Protease inhibitors

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

21 December 2006 Application Accepted

  Published as AU-B-2001281979

19 April 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001281980-Dermal application system for amino laevulinic acid

2001281978